Predictability of the Oxford classification of IgA nephropathy in Henoch-Schonlein purpura nephritis

被引:5
|
作者
Luo, Xinyao [2 ]
Tan, Jiaxing [2 ]
Wan, Dingyuan [2 ]
Chen, Junda [2 ]
Hu, Yahong [1 ]
机构
[1] Chinese Peoples Liberat Army, Gen Hosp Western Theater Command, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Sch Med, Chengdu, Sichuan, Peoples R China
关键词
Oxford classification; Henoch-Schonlein purpura nephritis; Prognosis; LONG-TERM OUTCOMES; CHILDREN; ADULTS; MULTICENTER; VALIDATION; CRESCENTS; PATHOPHYSIOLOGY; PREDICTORS;
D O I
10.1007/s11255-021-02861-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Whether the Oxford classification of immunoglobulin A nephropathy can be utilized to predict the adverse renal outcome of Henoch-Schonlein purpura nephritis (HSPN) has been long-debated. We, therefore, performed a meta-analysis to evaluate the prognostic value of Oxford classification lesions in HSPN. Methods We systematically searched Medline, EMBASE, Web of Science, and the Cochrane Library for articles published from January 1970 to August 2020. Cohort and case-control studies investigating the correlation between the Oxford classification and renal outcome were included, the quality of which was assessed by the Newcastle-Ottawa scale criteria. The pooled odds ratios (ORs) with their 95% confidence intervals (CIs) were calculated with a random-effects model or a fixed-effects model depending on the heterogeneity. Results A total of 485 papers were reviewed and eventually 9 comparisons were included, providing data of 1688 patients with HSPN. ORs for adverse renal events were 2.83 (95% CI 1.84-4.35; P < 0.001), 1.96 (95% CI 1.28-2.98; P < 0.05), and 5.45 (95% CI, 3.15-9.45; P < 0.001) for patients with lesions of endocapillary hypercellularity (E), segmental sclerosis (S), and tubular atrophy /interstitial fibrosis (T), respectively, without significant heterogeneity (E: I-2 = 0.0%; P = 0.498; S: I-2 = 22.4%; P = 0.258; T: I-2 = 33.6%; P = 0.171). Subgroup analysis adjusted for age also supported the results that E, S, and T lesions could serve as poor predictors (P < 0.05). Additionally, crescents (C) were strongly associated with renal outcome (OR 2.22; 95% CI 1.62-3.04; P < 0.001), with moderate heterogeneity (I-2 = 49.3%; P = 0.066). However, it should be noted that it is not the presence but the proportions of crescent lesions that were related to the high risk of progression to adverse renal events, because the predictability of lower rates of crescent (C1, with crescents > 0 and <= 25%) was uncertain (OR 2.21; 95% CI 0.75-6.51; P > 0.05). Although the pooled OR revealed that lesions of mesangial hypercellularity (M) were correlated with poor renal prognosis (OR 2.41; 95% CI 1.07-5.43; P < 0.05), subgroup analysis separating children from adults indicated that there seemed to be no significant difference. Conclusions Oxford classification, especially for E, S, T, and C, might be recommended for patients with HSPN, regardless of children and adults.
引用
收藏
页码:99 / 109
页数:11
相关论文
共 50 条
  • [31] Intraglomerular deposition of intact cross-linked fibrin in IgA nephropathy and Henoch-Schonlein purpura nephritis
    Ono, T
    Muso, E
    Suyama, K
    Oyama, A
    Matsushima, H
    Yashiro, M
    Kuwahara, T
    Yoshida, H
    Kanatsu, K
    Sasayama, S
    NEPHRON, 1996, 74 (03): : 522 - 528
  • [32] Value of the modified semiquantitative classification in predicting outcomes in children with Henoch-Schonlein purpura nephritis
    Wang, Yuhao
    Jiao, Jia
    Wan, Junli
    Wu, Daoqi
    Zhang, Gaofu
    Chan, Han
    Wang, Mo
    Chan, Xuelan
    Yang, Haiping
    Li, Qiu
    NEPHROLOGY, 2023, 28 (09) : 495 - 505
  • [33] Comparison between adults and children with Henoch-Schonlein purpura nephritis
    Lu, Shan
    Liu, Dong
    Xiao, Jing
    Yuan, Wenming
    Wang, Xiaoyang
    Zhang, Xiaoxue
    Zhang, Jin
    Liu, Zhangsuo
    Zhao, Zhanzheng
    PEDIATRIC NEPHROLOGY, 2015, 30 (05) : 791 - 796
  • [34] The pathogenesis and treatment of pediatric Henoch-Schonlein purpura nephritis
    Kawasaki, Yukihiko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (05) : 648 - 657
  • [35] Activation of Complement System in Henoch-Schonlein Purpura Nephritis
    Jang, Hea Min
    Baek, Heesun
    Han, Man Hoon
    Kim, Yong Jin
    Kim, Chan-Duck
    Kim, Yong-Lim
    Park, Sun-Hee
    Cho, Min Hyun
    FETAL AND PEDIATRIC PATHOLOGY, 2022, 41 (01) : 29 - 36
  • [36] Necessity and choice of therapy for Henoch-Schonlein purpura nephritis
    Kurokawa, Mari
    Maehara, Kenji
    Kaku, Yoshitsugu
    Honjo, Satoshi
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [37] Association of endothelial nitric oxide synthase gene polymorphism with the risk of Henoch-Schonlein purpura/Henoch-Schonlein purpura nephritis
    Zhong, Weiqiang
    Zhou, Tian-Biao
    Jiang, Zongpei
    RENAL FAILURE, 2015, 37 (03) : 372 - 376
  • [38] The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schonlein purpura nephritis
    Koskela, Mikael
    Ylinen, Elisa
    Ukonmaanaho, Elli-Maija
    Autio-Harmainen, Helena
    Heikkila, Paivi
    Lohi, Jouko
    Jauhola, Outi
    Ronkainen, Jaana
    Jahnukainen, Timo
    Nuutinen, Matti
    PEDIATRIC NEPHROLOGY, 2017, 32 (07) : 1201 - 1209
  • [39] Clinical outcomes, when matched at presentation, do not vary between adult-onset Henoch-Schonlein purpura nephritis and IgA nephropathy
    Oh, Hyung Jung
    Ahn, Song Vogue
    Yoo, Dong Eun
    Kim, Seung Jun
    Shin, Dong Ho
    Lee, Mi Jung
    Kim, Hyoung Rae
    Park, Jung Tak
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Choi, Kyu Hun
    Han, Seung Hyeok
    KIDNEY INTERNATIONAL, 2012, 82 (12) : 1304 - 1312
  • [40] The Combination of Mycophenolate Mofetil with Corticosteroids Induces Remission of Henoch-Schonlein Purpura Nephritis
    Ren, Pingping
    Han, Fei
    Chen, Liangliang
    Xu, Yu
    Wang, Ying
    Chen, Jianghua
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (03) : 271 - 277